The Food and Drug Administration has issued Emergency Use Authorization for Abbott’s AdviseDx SARS-CoV-2 IgM (immunoglobulin M) lab-based serology test for use on the Architect and Alinity platforms.
The current COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a betacoronavirus that causes severe acute respiratory distress in a significant proportion of ...
CHICAGO (NewsNation Now) — The U.S. Food and Drug Administration (FDA) issued an emergency use approval for Abbott’s latest lab-based COVID-19 IgM antibody test, the company announced Monday. Abbott ...
"Our new SARS-CoV-2 IgM assay provides information about an individual's immune status with a positive predictive value of 95.5% in a population with disease incidence as low as 3%," said Julie Sawyer ...
Announcing a new article publication for Zoonoses journal. The COVID-19 pandemic, which was caused by SARS-CoV-2, has had a significant effect on global public health, economies, and societies ...
EXTON, Pa., Nov. 23, 2020 /PRNewswire/ -- Frontage Labs has successfully launched an outstanding new initiative in support of both our local community and the global response to the COVID-19 pandemic.
SAN FRANCISCO, Calif. (KRON) — The U.S. Food and Drug Administration on Monday gave Emergency Use Authorization for Abbott’s IgM coronavirus antibody test. The IgM, or Immunoglobulin M, antibody test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results